GUANGZHOU, China, Dec. 1 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a leading developer and distributor of prescription and over the counter pharmaceuticals, traditional Chinese medicines (TCM), nutritional and dietary supplements, and medical devices and medical formulations today announced that the Company was awarded GSP (Good Supply Practice for Pharmaceutical Products) certification from the Guangdong Food and Drug Administration (Guangdong FDA).
The GSP certification is given to pharmaceutical distributors that meet with the designated quality control systems required by the Guangdong FDA, which evaluates the management of employees, facility, inventory, sales and distribution systems, as well as product management systems. A stringent quality control system is required by the Chinese government to protect the integrity of the pharmaceutical industry in China as distributors are mandated to be GSP certified in order to engage in the pharmaceutical distribution business in China.
In conjunction with China Medicine's success in obtaining the GSP certification, the Company will also be considered by the Guangdong FDA to include dentistry medical devices and instruments, peptide praeparatum and protein anabolica in its distribution product offering. The Company expects to receive the official approval in approximately 7 days for the aforementioned products.
"We are honored to have received the GSP certification and we will
continue to promote and improve our quality control system to ensure the
safety of the pharmaceutical products we distribute to the public," said Mr.
Senshan Yang, Chairman and CEO of China Medicine Corporation. "Recently, we
moved our warehouse to one that is double the size of the previous warehouse
and is well furnished with state-of-the-art equipment, which includes a
refrigeration storage facility. We
|SOURCE China Medicine Corporation|
Copyright©2008 PR Newswire.
All rights reserved